Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Seven Solutions for Neuroprotection in Parkinson's Disease
David Devos, Étienne C. Hirsch, Richard Wyse
Movement Disorders (2020) Vol. 36, Iss. 2, pp. 306-316
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The Vitamin D Receptor as a Potential Target for the Treatment of Age-Related Neurodegenerative Diseases Such as Alzheimer’s and Parkinson’s Diseases: A Narrative Review
Władysław Lasoń, Danuta Jantas, Monika Leśkiewicz, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 660-660
Open Access | Times Cited: 56
Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Paul Edison
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 217-229
Open Access | Times Cited: 66
A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn (“line 61”) Mice
Franziska Richter, Miloš Stanojlović, Christopher Käufer, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 1, pp. 97-116
Open Access | Times Cited: 23
Advances in fluorescent probe development for bioimaging of potential Parkinson's biomarkers
Xiaoqian Sun, Qingqing Jiang, Yu Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116195-116195
Closed Access | Times Cited: 12
The Disease Modification Conundrum in Parkinson’s Disease: Failures and Hopes
Zoltán Mari, Tiago Mestre
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 30
Rescue of Dopamine Neurons from Iron-Dependent Ferroptosis by Doxycycline and Demeclocycline and Their Non-Antibiotic Derivatives
Aurore Tourville, Sarah Viguier, Florencia González‐Lizárraga, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 575-575
Open Access | Times Cited: 15
Hypoxia Sensing and Responses in Parkinson’s Disease
Johannes Burtscher, Yves Duderstadt, Hannes Gatterer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1759-1759
Open Access | Times Cited: 5
Characterizing Disease Progression in Parkinson’s Disease from Videos of the Finger Tapping Test
Diego L. Guarín, Joshua K. Wong, Nikolaus R. McFarland, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering (2024) Vol. 32, pp. 2293-2301
Open Access | Times Cited: 5
Analysis of Voice in Parkinson’s Disease Utilizing the Acoustic Voice Quality Index
Rachel B. Convey, Anne-Maria Laukkanen, Sari Ylinen, et al.
Journal of Voice (2024)
Closed Access | Times Cited: 4
Pharmacotherapy for Disease Modification in Early Parkinson’s Disease: How Early Should We Be?
Philipp Mahlknecht, Werner Poewe
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S407-S421
Open Access | Times Cited: 4
Advantages and Challenges of Platform Trials for Disease Modifying Therapies in Parkinson's Disease
Margherita Fabbri, Olivier Rascol, Thomas Foltynie, et al.
Movement Disorders (2024) Vol. 39, Iss. 9, pp. 1468-1477
Closed Access | Times Cited: 4
Disease-Modifying Therapies in Parkinson’s Disease
Margherita Fabbri, Jean‐Christophe Corvol, Olivier Rascol
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 319-340
Closed Access
Erianin isolated from Dendrobium huoshanense alleviated neuroinflammation in MPTP-induced Parkinson's disease model via NF-κB/NLRP3 pathway
Connie Yan, Z. Ryan Tian, Weiquan Ruan, et al.
Journal of Ethnopharmacology (2025), pp. 119620-119620
Closed Access
Oxytetracycline and its Non-Antibiotic Derivative DOT Protect Midbrain Dopamine Neurons from Iron-Driven Oxidative Damage
Telma Fernandes, Aurore Tourville, Ismaïla Ciss, et al.
Neurotoxicity Research (2025) Vol. 43, Iss. 2
Closed Access
Crowdsourcing Proposal Supporting Patient Engagement in Parkinson's Disease: A Digital Research Environment (DRE)‐Enabled, Patient Swarm Approach to Develop QSP Models
J. Barrett, Benedetto Piccoli, Christopher Denaro, et al.
The Journal of Clinical Pharmacology (2025)
Closed Access
Acupuncture for Parkinson’s disease: From theory to practice
Jingqi Fan, Wei-Jing Lu, Weiqiang Tan, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112907-112907
Open Access | Times Cited: 16
Microvascular blood-brain barrier alterations in isolated brain capillaries of mice over-expressing alpha-synuclein (Thy1-aSyn line 61)
Kristina Lau, Lisa T. Porschen, Franziska Richter, et al.
Neurobiology of Disease (2023) Vol. 187, pp. 106298-106298
Open Access | Times Cited: 8
Potential Therapeutic Effects of Policosanol from Insect Wax on Caenorhabditis elegans Models of Parkinson’s Disease
Chenjing Ma, Ying Feng, Xian Li, et al.
Journal of Neuroimmune Pharmacology (2023) Vol. 18, Iss. 1-2, pp. 127-144
Closed Access | Times Cited: 7
Editorial: Early detection of neurodegenerative disorders using behavioral markers and new technologies: New methods and perspectives
Valéria Manera, Erika Rovini, Peter E. Wais
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 7
Free-water diffusion magnetic resonance imaging under selegiline treatment in Parkinson's disease
Haruka Takeshige‐Amano, Taku Hatano, Koji Kamagata, et al.
Journal of the Neurological Sciences (2024) Vol. 457, pp. 122883-122883
Open Access | Times Cited: 2
Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson’s disease
Angela Minnella, Kevin P. McCusker, Akiko Amagata, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0309893-e0309893
Open Access | Times Cited: 2
Assessing REM Sleep Behaviour Disorder: From Machine Learning Classification to the Definition of a Continuous Dissociation Index
Irene Rechichi, Antonella Iadarola, Maurizio Zibetti, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 19, Iss. 1, pp. 248-248
Open Access | Times Cited: 14
The etiopathogenetic and pathophysiological spectrum of parkinsonism
Matteo Bologna, Daniel Truong, Joseph Jankovic
Journal of the Neurological Sciences (2021) Vol. 433, pp. 120012-120012
Open Access | Times Cited: 13
Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioral tests
Francesco Gubinelli, G. Cazzolla, Matilde Negrini, et al.
Behavioural Brain Research (2022) Vol. 429, pp. 113887-113887
Open Access | Times Cited: 9
Mitochondrial electron transport chain defects modify Parkinson's disease phenotypes in a Drosophila model
Maria E. O'Hanlon, Clare Tweedy, Filippo Scialò, et al.
Neurobiology of Disease (2022) Vol. 171, pp. 105803-105803
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top